Multitract microtransplantation increases the yield of DARPP-32-positive embryonic striatal cells in a rodent model of huntington's disease

Cell Transplantation

Volumn 20, Issue 10, 2011, Pages 1515-1527

  Jiang, Wei ^a,b   Büchele, Fabian ^a   Papazoglou, Anna ^a   Döbrössy, Máté ^a   Nikkhah, Guido ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Embryonic striatal neurons; Green fluorescent protein (GFP); Huntington's disease model; Microtransplantation; Multitract

Indexed keywords

GREEN FLUORESCENT PROTEIN; PHOSPHOPROTEIN DARPP 32;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CELL TRANSPLANTATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FEMALE; HISTOLOGY; HUNTINGTON CHOREA; NONHUMAN; PRIORITY JOURNAL; RAT;

RATTUS; RODENTIA;

EID: 84856061919     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X547435     Document Type: Article

References (57)

1. Abrous, N.; Guy, J.; Vigny, A.; Calas, A.; Le Moal, M.; Herman, J. P. Development of intracerebral dopaminergic grafts: A combined immunohistochemical and autoradiographic study of its time course and environmental influences. J. Comp. Neurol. 273:26-41; 1988.
2. Alberch, J.; Pérez-Navarro, E.; Canals, J. M. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease. Brain Res. Bull. 57:817-822; 2002.
3. Asada, H.; Ip, N. Y.; Pan, L.; Razack, N.; Parfitt, M. M.; Plunkett, R. J. Time course of ciliary neurotrophic factor 1526 mRNA expression is coincident with the presence of protoplasmic astrocytes in traumatized rat striatum. J. Neurosci. Res. 40:22-30; 1995.
4. Aubry, L.; Bugi, A.; Lefort, N.; Rousseau, F.; Peschanski, M.; Perrier, A. L. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc. Natl. Acad. Sci. USA 105:16707-16712; 2008.
5. Bachoud-Lévi, A. Neural grafts in Huntington's disease: Viability after 10 years. Lancet Neurol. 8:979-981; 2009.
6. Bachoud-Lévi, A.; Gaura, V.; Brugières, P.; Lefaucheur, J.; Boissé, M.; Maison, P.; Baudic, S.; Ribeiro, M. J.; Bourdet, C.; Remy, P.; Cesaro, P.; Hantraye, P.; Peschanski, M. Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: A long-term follow-up study. Lancet Neurol. 5:303-309; 2006.
7. Baker-Cairns, B. J.; Sloan, D. J.; Broadwell, R. D.; Puklavec, M.; Charlton, H. M. Contributions of donor and host blood vessels in CNS allografts. Exp. Neurol. 142:36-46; 1996.
8. Batchelor, P. E.; Liberatore, G. T.; Wong, J. Y.; Porritt, M. J.; Frerichs, F.; Donnan, G. A.; Howells, D. W. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci. 19:1708-1716; 1999.
9. Brandis, A.; Kuder, H.; Knappe, U.; Jödicke, A.; Schönmayr, R.; Samii, M.; Walter, G. F.; Nikkhah, G. Timedependent expression of donorand host-specific major histocompatibility complex class I and II antigens in allogeneic dopamine-rich macroand micrografts: Comparison of two different grafting protocols. Acta Neuropathol. 95:85-97; 1998.
10. Brundin, P.; Karlsson, J.; Emgrd, M.; Schierle, G. S.; Hansson, O.; Petersén, A.; Castilho, R. F. Improving the survival of grafted dopaminergic neurons: A review over current approaches. Cell Transplant. 9:179-195; 2000.
11. Canals, J. M.; Checa, N.; Marco, S.; Akerud, P.; Michels, A.; Perez-Navarro, E.; Tolosa, E.; Arenas, E.; Alberch, J. Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area. J. Neurosci. 21:117-124; 2001.
12. Canals, J. M.; Marco, S.; Checa, N.; Michels, A.; PrezNavarro, E.; Arenas, E.; Alberch, J. Differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor, and neurotrophin-3 after excitotoxicity in a rat model of Huntington's disease. Neurobiol. Dis. 5:357-364; 1998.
13. Capetian, P.; Knoth, R.; Maciaczyk, J.; Pantazis, G.; Ditter, M.; Bokla, L.; Landwehrmeyer, G. B.; Volk, B.; Nikkhah, G. Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation. Neuroscience 160:661-675; 2009.
14. Carli, M.; Evenden, J. L.; Robbins, T. W. Depletion of unilateral striatal dopamine impairs initiation of contralateral actions and not sensory attention. Nature 313:679682; 1985.
15. Casper, D.; Finkelstein, E.; Goldstein, I. M.; Palencia, D.; Yunger, Y.; Pidel, A. Dopaminergic neurons associate with blood vessels in neural transplants. Exp. Neurol. 184: 785-793; 2003.
16. Deckel, A. W.; Moran, T. H.; Coyle, J. T.; Sanberg, P. R.; Robinson, R. G. Anatomical predictors of behavioral recovery following fetal striatal transplants. Brain Res. 365:249-258; 1986.
17. Dobrossy, M. D.; Dunnett, S. Training specificity, graft JIANG ET AL. development and graft-mediated functional recovery in a rodent model of Huntington's disease. Neuroscience 132: 543-552; 2005.
18. Dobrossy, M. D.; Dunnett, S. B. Morphological and cellular changes within embryonic striatal grafts associated with enriched environment and involuntary exercise. Eur. J. Neurosci. 24:3223-3233; 2006.
19. Dobrossy, M. D.; Dunnett, S. B. Environmental housing and duration of exposure affect striatal graft morphology in a rodent model of Huntington's disease. Cell Transplant. 17:1125-1134; 2008.
20. Duan, W.; Widner, H.; Cameron, R. M.; Brundin, P. Quinolinic acid-induced inflammation in the striatum does not impair the survival of neural allografts in the rat. Eur. J. Neurosci. 10:2595-2606; 1998.
21. Finger, S.; Dunnett, S. B. Nimodipine enhances growth and vascularization of neural grafts. Exp. Neurol. 104: 1-9; 1989.
22. Francis, J. S.; Olariu, A.; Kobayashi, E.; Leone, P. GFPtransgenic Lewis rats as a cell source for oligodendrocyte replacement. Exp. Neurol. 205:177-189; 2007.
23. Fricker, R. A.; Torres, E. M.; Dunnett, S. B. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. I. Morphological characteristics. Neuroscience 79:695-710; 1997.
24. Fricker, R. A.; Torres, E. M.; Hume, S. P.; Myers, R.; Opacka-Juffrey, J.; Ashworth, S.; Brooks, D. J.; Dunnett, S. B. The effects of donor stage on the survival and function of embryonic striatal grafts in the adult rat brain. II. Correlation between positron emission tomography and reaching behaviour. Neuroscience 79:711-721; 1997.
25. Fricker-Gates, R. A.; White, A.; Gates, M. A.; Dunnett, S. B. Striatal neurons in striatal grafts are derived from both post-mitotic cells and dividing progenitors. Eur. J. Neurosci. 19:513-520; 2004.
26. Gallina, P.; Paganini, M.; Lombardini, L.; Mascalchi, M.; Porfirio, B.; Gadda, D.; Marini, M.; Pinzani, P.; Salvianti, F.; Crescioli, C.; Bucciantini, S.; Mechi, C.; Sarchielli, E.; Romoli, A. M.; Bertini, E.; Urbani, S.; Bartolozzi, B.; De Cristofaro, M. T.; Piacentini, S.; Saccardi, R.; Pupi, A.; Vannelli, G. B.; Di Lorenzo, N. Human striatal neuroblasts develop and build a striatal-like structure into the brain of Huntington's disease patients after transplantation. Exp. Neurol. 222:30-41; 2010.
27. Ho, A. Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1β in the striatum of young and middle-aged mice. Exp. Neurol. 148:348-359; 1997.
28. Inoue, H.; Ohsawa, I.; Murakami, T.; Kimura, A.; Hakamata, Y.; Sato, Y.; Kaneko, T.; Takahashi, M.; Okada, T.; Ozawa, K.; Francis, J.; Leone, P.; Kobayashi, E. Development of new inbred transgenic strains of rats with LacZ or GFP. Biochem. Biophys. Res. Commun. 329:288-295; 2005.
29. Isacson, O.; Dunnett, S. B.; Bjrklund, A. Graft-induced behavioral recovery in an animal model of Huntington disease. Proc. Natl. Acad. Sci. USA 83:2728-2732; 1986.
30. Jiang, W.; Buchele, F.; Papazoglou, A.; Dobrossy, M.; Nikkhah, G. Ketamine anaesthesia interferes with the quinolinic acid-induced lesion in a rat model of Huntington's disease. J. Neurosci. Methods 179:219-223; 2009.
31. Langley, K. C.; Bergson, C.; Greengard, P.; Ouimet, C. C. Co-localization of the D1 dopamine receptor in a subset of DARPP-32-containing neurons in rat caudate-putamen. Neuroscience 78:977-983; 1997.
32. Maurer, M. H.; Thomas, C.; Brgers, H. F.; Kuschinsky, W. Transplantation of adult neural progenitor cells transfected with vascular endothelial growth factor rescues grafted cells in the rat brain. Int. J. Biol. Sci. 4:1-7; 2008.
33. Mizuno, K.; Carnahan, J.; Nawa, H. Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. Dev. Biol. 165:243-256; 1994.
34. Mundt-Petersen, U.; Karlsson, J.; Schierle, G. S.; Brundin, P. Pretreatment with MK-801 or the lazaroid U-83836E does not enhance striatal graft survival. Cell Transplant. 9:73-78; 2000.
35. Mundt-Petersen, U.; Petersén, A.; Emgård, M.; Dunnett, S. B.; Brundin, P. Caspase inhibition increases embryonic striatal graft survival. Exp. Neurol. 164:112-120; 2000.
36. Nakao, N.; Brundin, P.; Funa, K.; Lindvall, O.; Odin, P. Trophic and protective actions of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro. Brain Res. Dev. Brain Res. 90:92-101; 1995.
37. Nakao, N.; Grasbon-Frodl, E. M.; Widner, H.; Brundin, P. DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease. Neuroscience 74:959-970; 1996.
38. Nakao, N.; Itakura, T. Fetal tissue transplants in animal models of Huntington's disease: The effects on damaged neuronal circuitry and behavioral deficits. Prog. Neurobiol. 61:313-338; 2000.
39. Nakao, N.; Kokaia, Z.; Odin, P.; Lindvall, O. Protective effects of BDNF and NT-3 but not PDGF against hypoglycemic injury to cultured striatal neurons. Exp. Neurol. 131(1):1-10; 1995.
40. Nakao, N.; Odin, P.; Lindvall, O.; Brundin, P. Differential trophic effects of basic fibroblast growth factor, insulinlike growth factor-1, and neurotrophin-3 on striatal neurons in culture. Exp. Neurol. 138:144-157; 1996.
41. Nikkhah, G.; Cunningham, M. G.; Jodicke, A.; Knappe, U.; Bjorklund, A. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res. 633: 133-143; 1994.
42. Nikkhah, G.; Olsson, M.; Eberhard, J.; Bentlage, C.; Cunningham, M. G.; Bjorklund, A. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: A detailed account of the methodology. Neuroscience 63:57-72; 1994.
43. Nikkhah, G.; Rosenthal, C.; Falkenstein, G.; Roedter, A.; Papazoglou, A.; Brandis, A. Microtransplantation of dopaminergic cell suspensions: Further characterization and optimization of grafting parameters. Cell Transplant. 18: 119-133; 2009.
44. Nikkhah, G.; Winkler, C.; Roedter, A.; Samii, M. Microtransplantation of nigral dopamine neurons: A "step-bystep" recipe. In: Dunnett, S. B.; Baker, G., eds. Cell and tissue transplantation in the CNS. Totowa, NJ: Humana Press Inc.; 2000:207-231. 1527
45. Olson, L.; Seiger, A. Early prenatal ontogeny of central monoamine neurons in the rat: Fluorescence histochemical observations. Z. Anat. Entwicklungsgesch. 137:301-316; 1972.
46. Ouimet, C. C.; Greengard, P. Distribution of DARPP-32 in the basal ganglia: An electron microscopic study. J. Neurocytol. 19:39-52; 1990.
47. Petersén, A.; Brundin, P. Effects of ciliary neurotrophic factor on excitotoxicity and calcium-ionophore A23187induced cell death in cultured embryonic striatal neurons. Exp. Neurol. 160:402-412; 1999.
48. Petersén, A.; Emgård, M.; Brundin, P. Impact of a preceding striatal excitotoxic lesion and treatment with ciliary neurotrophic factor on striatal graft survival. Brain Res. Bull. 50:275-281; 1999.
49. Seiger, A.; Olson, L. Late prenatal ontogeny of central monoamine neurons in the rat: Fluorescence histochemical observations. Z. Anat. Entwicklungsgesch. 140:281-318; 1973.
50. Sinclair, S. R.; Fawcett, J. W.; Dunnett, S. B. Dopamine cells in nigral grafts differentiate prior to implantation. Eur. J. Neurosci. 11:4341-4348; 1999.
51. Sortwell, C. E. Strategies for the augmentation of grafted dopamine neuron survival. Front. Biosci. 8:522-532; 2003.
52. Steiner, B.; Winter, C.; Blumensath, S.; Paul, G.; Harnack, D.; Nikkhah, G.; Kupsch, A. Survival and functional recovery of transplanted human dopaminergic neurons into hemiparkinsonian rats depend on the cannula size of the implantation instrument. J. Neurosci. Methods 169:128134; 2008.
53. Ventimiglia, R.; Mather, P. E.; Jones, B. E.; Lindsay, R. M. The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur. J. Neurosci. 7: 213-222; 1995.
54. Watts, C.; Brasted, P. J.; Dunnett, S. B. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease. Exp. Neurol. 163:85-97; 2000.
55. Watts, C.; Caldwell, M. A.; Dunnett, S. B. The development of intracerebral cell-suspension implants is influenced by the grafting medium. Cell Transplant. 7:573583; 1998.
56. Watts, C.; Dunnett, S. B. Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: Implications for timing of surgical intervention. J. Neurosurg. 89:267-274; 1998.
57. Watts, C.; Dunnett, S. B. Towards a protocol for the preparation and delivery of striatal tissue for clinical trials of transplantation in Huntington's disease. Cell Transplant. 9:223-234; 2000.